Literature DB >> 514370

Incorporation of inositol hexaphosphate into intact red blood cells. I. Fusion of effector-containing lipid vesicles with erythrocytes.

C Nicolau, K Gersonde.   

Abstract

Fluid charged lipid vesicles loaded with an inositol hexaphosphate solution were used to transport this allosteric effector into human intact red blood cells. Rate and extent of uptake of the vesicles and of the effector by the red blood cells were measured as changes in the O2 half-saturation pressure and the 31P-NMR spectra of the intracellular inositol hexaphosphate-haemoglobin complex.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 514370     DOI: 10.1007/bf00368810

Source DB:  PubMed          Journal:  Naturwissenschaften        ISSN: 0028-1042


  17 in total

1.  Thermodynamical studies of oxygen equilibrium of hemoglobin. Nonuniform heats and entropy changes for the individual oxygenation steps and enthalpy-entropy compensation.

Authors:  K Imai; T Yonetani
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

2.  Complete exchangeability of cholesterol in phosphatidylcholine/cholesterol vesicles of different degrees of unsaturation.

Authors:  B Bloj; D B Zilversmit
Journal:  Biochemistry       Date:  1977-09-06       Impact factor: 3.162

3.  The influence of electrostatic interaction on the proton-binding behaviour of myo-inositol hexakisphosphate.

Authors:  E R Zuiderweg; G G van Beek; S H de Bruin
Journal:  Eur J Biochem       Date:  1979-02-15

4.  Association of glyceraldehyde 3-phosphate dehydrogenase with the human erythrocyte membrane. Effect of detergents, trypsin, and adenosine triphosphate.

Authors:  B C Shin; K L Carraway
Journal:  J Biol Chem       Date:  1973-02-25       Impact factor: 5.157

5.  Electrophoretic analysis of the major polypeptides of the human erythrocyte membrane.

Authors:  G Fairbanks; T L Steck; D F Wallach
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

6.  Difference in microviscosity induced by different cholesterol levels in the surface membrane lipid layer of normal lymphocytes and malignant lymphoma cells.

Authors:  M Shinitzky; M Inbar
Journal:  J Mol Biol       Date:  1974-01-05       Impact factor: 5.469

7.  Characteristics of the permeability barrier of human erythrocyte ghosts to non-electrolytes.

Authors:  C Y Jung; L M Carlson; C J Balzer
Journal:  Biochim Biophys Acta       Date:  1973-02-27

8.  Microviscosity and order in the hydrocarbon region of phospholipid and phospholipid-cholesterol dispersions determined with fluorescent probes.

Authors:  U Cogan; M Shinitzky; G Weber; T Nishida
Journal:  Biochemistry       Date:  1973-01-30       Impact factor: 3.162

9.  Liposome--lymphocyte interaction: saturable sites for transfer and intracellular release of liposome contents.

Authors:  R Blumenthal; J N Weinstein; S O Sharrow; P Henkart
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  Improvement of the red blood cell O2 release capacity by lipid vesicle-mediated incorporation of inositol hexaphosphate.

Authors:  K Gersonde; C Nicolau
Journal:  Blut       Date:  1979-07
View more
  4 in total

1.  Incorporation of inositol into intact red blood cells. II. Enhancement of gas transport in inositol hexaphosphate-loaded red blood cells.

Authors:  K Gersonde; C Nicolau
Journal:  Naturwissenschaften       Date:  1979-11

2.  Improvement of the red blood cell O2 release capacity by lipid vesicle-mediated incorporation of inositol hexaphosphate.

Authors:  K Gersonde; C Nicolau
Journal:  Blut       Date:  1979-07

Review 3.  Recent advancements in erythrocytes, platelets, and albumin as delivery systems.

Authors:  Peipei Xu; Ruju Wang; Xiaohui Wang; Jian Ouyang
Journal:  Onco Targets Ther       Date:  2016-05-17       Impact factor: 4.147

Review 4.  Drug-loaded erythrocytes: on the road toward marketing approval.

Authors:  Vanessa Bourgeaux; José M Lanao; Bridget E Bax; Yann Godfrin
Journal:  Drug Des Devel Ther       Date:  2016-02-11       Impact factor: 4.162

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.